SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 496.44 |
| Enterprise Value ($M) | 474.97 |
| Book Value ($M) | 152.27 |
| Book Value / Share | 0.76 |
| Price / Book | 3.26 |
| NCAV ($M) | 72.47 |
| NCAV / Share | 0.36 |
| Price / NCAV | 6.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.82 |
| Return on Assets (ROA) | -0.55 |
| Return on Equity (ROE) | -0.67 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.07 |
| Current Ratio | 4.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 115.98 |
| Assets | 195.78 |
| Liabilities | 43.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.31 |
| Operating Income | -102.69 |
| Net Income | -149.27 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -82.44 |
| Cash from Investing | 59.17 |
| Cash from Financing | 5.37 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Galaxy Group Funding ECI U LLC | 4.20 | -21.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,011,851 | 5,561,411 | 36.18 | |
| 429,318 | 1,324,971 | 32.40 | |
| 418,877 | 1,728,527 | 24.23 | |
| 607,791 | 2,847,058 | 21.35 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AQST – Aquestive Therapeutics, Inc. | ARCT – Arcturus Therapeutics Holdings Inc. |
| ARDX – Ardelyx, Inc. | ATXS – Astria Therapeutics, Inc. |
| AUPH – Aurinia Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io